Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients

IF 4.6 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Pierre Henri Ducluzeau , Grégoire Fauchier , Julien Herbert , Carl Semaan , Jean Michel Halimi , Denis Angoulvant , Laurent Fauchier
{"title":"Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients","authors":"Pierre Henri Ducluzeau ,&nbsp;Grégoire Fauchier ,&nbsp;Julien Herbert ,&nbsp;Carl Semaan ,&nbsp;Jean Michel Halimi ,&nbsp;Denis Angoulvant ,&nbsp;Laurent Fauchier","doi":"10.1016/j.diabet.2023.101429","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) increase risks of cardiovascular (CV) and renal disease compared with diabetes-free populations. There are only a few studies comparing T1DM and T2DM for the relative risk of these clinical events.</p></div><div><h3>Methods</h3><p>All adult patients hospitalized in French hospitals in 2013 with at least 5 years of follow-up were identified and categorized by their diabetes status. A total of 50,623 patients with T1DM (age 61.4 ± 18.6, 53% male) and 425,207 patients with T2DM (age 68.6 ± 14.3, 55% male) were followed over a median period of 5.3 years (interquartile range: 2.8 - 5.8 years). Prevalence and event rates of myocardial infarction (MI), heart failure (HF), ischemic stroke, chronic kidney disease (CKD), all-cause death and CV death were assessed with age stratification of 10-year intervals. For clinical events during follow-up, we report hazard ratios (HRs) in T1DM relative to T2DM.</p></div><div><h3>Results</h3><p>The age and sex-adjusted prevalence of CV diseases was higher in T2DM for ages above 40 years whereas the prevalence of CKD was more common in T1DM between ages 18 and 70 years. During 2,033,239 person-years of follow-up, age and sex-adjusted HR event rates comparing T1DM, versus T2DM as reference, showed that MI and HF relative risks were increased above 60 years (1.2 and 1.4 -fold). HR of ischemic stroke did not markedly differ between T1DM and T2DM. Risk of incident CKD was 2.4-fold higher in T1DM above 60 years. All-cause death HR risk was 1.1-fold higher in T1DM after 60 years and the CV death risk was 1.15-fold higher in T1DM between 60 and 69 years compared to T2DM.</p></div><div><h3>Conclusions</h3><p>Although the crude prevalent burden of CV diseases may be lower in T1DM than in T2DM, patients with T1DM may have a higher risk of incident MI, HF, all-cause death and CV death above 60 years of age, highlighting the need for improved prevention in this population.</p></div>","PeriodicalId":11334,"journal":{"name":"Diabetes & metabolism","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes & metabolism","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1262363623000113","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) increase risks of cardiovascular (CV) and renal disease compared with diabetes-free populations. There are only a few studies comparing T1DM and T2DM for the relative risk of these clinical events.

Methods

All adult patients hospitalized in French hospitals in 2013 with at least 5 years of follow-up were identified and categorized by their diabetes status. A total of 50,623 patients with T1DM (age 61.4 ± 18.6, 53% male) and 425,207 patients with T2DM (age 68.6 ± 14.3, 55% male) were followed over a median period of 5.3 years (interquartile range: 2.8 - 5.8 years). Prevalence and event rates of myocardial infarction (MI), heart failure (HF), ischemic stroke, chronic kidney disease (CKD), all-cause death and CV death were assessed with age stratification of 10-year intervals. For clinical events during follow-up, we report hazard ratios (HRs) in T1DM relative to T2DM.

Results

The age and sex-adjusted prevalence of CV diseases was higher in T2DM for ages above 40 years whereas the prevalence of CKD was more common in T1DM between ages 18 and 70 years. During 2,033,239 person-years of follow-up, age and sex-adjusted HR event rates comparing T1DM, versus T2DM as reference, showed that MI and HF relative risks were increased above 60 years (1.2 and 1.4 -fold). HR of ischemic stroke did not markedly differ between T1DM and T2DM. Risk of incident CKD was 2.4-fold higher in T1DM above 60 years. All-cause death HR risk was 1.1-fold higher in T1DM after 60 years and the CV death risk was 1.15-fold higher in T1DM between 60 and 69 years compared to T2DM.

Conclusions

Although the crude prevalent burden of CV diseases may be lower in T1DM than in T2DM, patients with T1DM may have a higher risk of incident MI, HF, all-cause death and CV death above 60 years of age, highlighting the need for improved prevention in this population.

与2型糖尿病患者相比,1型糖尿病患者心血管和肾脏疾病的患病率和发病率:一项法国全国住院患者观察性研究
背景与无糖尿病人群相比,1型糖尿病(T1DM)和2型糖尿病(T2DM)增加了心血管(CV)和肾脏疾病的风险。只有少数研究比较了T1DM和T2DM发生这些临床事件的相对风险。方法对2013年在法国医院住院的所有成年患者进行至少5年的随访,并根据其糖尿病状况进行分类。对50623名T1DM患者(年龄61.4±18.6,53%为男性)和425207名T2DM患者(68.6±14.3,55%为男性)进行了中位5.3年的随访(四分位间距:2.8-5.8年)。心肌梗死(MI)、心力衰竭(HF)、缺血性中风、慢性肾脏病(CKD)、全因死亡和CV死亡的患病率和事件率采用10年间隔的年龄分层进行评估。对于随访期间的临床事件,我们报告了T1DM相对于T2DM的危险比。结果40岁以上的T2DM患者经年龄和性别调整后的心血管疾病患病率较高,而18至70岁的T1DM患者CKD患病率更常见。在2033239人年的随访中,比较T1DM和T2DM作为参考的年龄和性别调整后的HR事件发生率表明,MI和HF的相对风险在60岁以上增加(1.2和1.4倍)。缺血性脑卒中的HR在T1DM和T2DM之间没有显著差异。60岁以上T1DM患者发生CKD的风险高2.4倍。与T2DM相比,60岁后T1DM的全因死亡HR风险高1.1倍,60至69岁期间T1DM的CV死亡风险高1.15倍。结论尽管T1DM的心血管疾病的粗略流行负担可能低于T2DM,但T1DM患者在60岁以上发生MI、HF、全因死亡和CV死亡的风险可能更高,强调需要改进这一人群的预防工作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes & metabolism
Diabetes & metabolism 医学-内分泌学与代谢
CiteScore
12.00
自引率
4.20%
发文量
86
审稿时长
13 days
期刊介绍: A high quality scientific journal with an international readership Official publication of the SFD, Diabetes & Metabolism, publishes high-quality papers by leading teams, forming a close link between hospital and research units. Diabetes & Metabolism is published in English language and is indexed in all major databases with its impact factor constantly progressing. Diabetes & Metabolism contains original articles, short reports and comprehensive reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信